Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Junichi TAKADA"'
Publikováno v:
Osteoporosis and Sarcopenia, Vol 6, Iss 1, Pp 8-14 (2020)
Objectives: Once-weekly teriparatide (W-TPTD) is an effective drug for patients with osteoporosis; however, some patients discontinue W-TPTD owing to its adverse drug reactions (ADRs). Sequential treatment with W-TPTD and antiresorptive therapy may b
Externí odkaz:
https://doaj.org/article/fad7641496f342e19762c90563091d76
Autor:
Junichi Takada, Hiroshi Wada, Kousuke Iba, Kouichi Sasaki, Takayuki Dohke, Kumiko Kanaya, Takashi Yoshizaki, Toshihiko Yamashita
Publikováno v:
Journal of Orthopaedic Surgery, Vol 24 (2016)
Purpose To evaluate the effect of combined use of ibandronate and eldecalcitol for 6 to 12 months on bone mineral density (BMD) and bone strength of the proximal femur in postmenopausal Japanese women with osteoporosis. Methods BMD and bone strength
Externí odkaz:
https://doaj.org/article/a810aeaf4fd34231b7ded4d5b89d82aa
Publikováno v:
Journal of Orthopaedic Surgery, Vol 20 (2012)
Purpose. To assess correlations between a bone resorption marker and the structural geometry of the proximal femur in raloxifene-treated postmenopausal women with osteoporosis. Methods. 45 postmenopausal, osteoporotic women aged 57 to 79 (mean, 67) y
Externí odkaz:
https://doaj.org/article/90b06426e0cf461f9906ca653e350363
Publikováno v:
Journal of Bone and Mineral Metabolism. 41:268-277
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32539a7ac0f65b9690a35293d2728731
https://doi.org/10.1007/s00774-023-01410-5
https://doi.org/10.1007/s00774-023-01410-5
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 82:1684-1688
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8c830d7c7ae1b17c5854cc0dc1b0e91
https://doi.org/10.3919/jjsa.82.1684
https://doi.org/10.3919/jjsa.82.1684
Autor:
Cesar Libanati, Junichi Takada, Rajani Dinavahi, Toshiyasu Hirama, Etsuro Hamaya, Cassandra E Milmont, Yoichi Nakamura, Akimitsu Miyauchi, Andreas Grauer
Publikováno v:
Journal of Bone and Mineral Metabolism. 38:310-315
Procollagen type I N-terminal propeptide (P1NP), a bone formation marker, reportedly predicts bone mineral density (BMD) response to teriparatide treatment in treatment-naive patients with osteoporosis. Results from a randomized, phase 3, open-label,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6942204984f7e1f3633c59e9a6f6f63
https://doi.org/10.1007/s00774-019-01057-1
https://doi.org/10.1007/s00774-019-01057-1
Autor:
S. Fujiwara, Masao Fukunaga, Osamu Chaki, Masaaki Inaba, Yasuo Imanishi, Junichi Takada, Noriko Yoshimura, Shoichi Ichimura, Takami Miki, Hiroshi Hagino, Masataka Shiraki, Yoshiki Nishizawa, Masakazu Miura, Hiroaki Ohta
Publikováno v:
Clinica Chimica Acta. 498:101-107
With the aging of society, the number of osteoporosis-related fractures is increasing. Prevention of osteoporosis and maintenance of the quality of life of osteoporosis patients require early diagnosis, effective treatment, and highly precise treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70210f4272090f9948e689cf299fab6b
https://doi.org/10.1016/j.cca.2019.08.012
https://doi.org/10.1016/j.cca.2019.08.012
Publikováno v:
Journal of Bone and Mineral Metabolism. 38:240-247
In terms of the balance between benefits and risks of long-term treatment with bisphosphonate, uncertainties remain regarding the optimal treatment duration. We investigated effects of continuous long-term treatment for 10 years with bisphosphonate i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abafa5e1842391ae78cd42e8b5c41d50
https://doi.org/10.1007/s00774-019-01049-1
https://doi.org/10.1007/s00774-019-01049-1
Autor:
Junichi Takada, Megumu Yamamura, Tsuneo Takebayashi, Takayuki Dohke, Toshihiko Yamashita, Kousuke Iba, Tomohiro Akatsuka, Osamu Yamamoto, Akira Saito
Publikováno v:
Journal of bone and mineral metabolism. 39(5)
The occurrence of early adverse events and the factors associated with these events in zoledronic acid-treated Japanese patients with osteoporosis were investigated. All patients treated with zoledronic acid for the first time for primary osteoporosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a44ac184aed3f8aa5ce348421dd3cda1
https://pubmed.ncbi.nlm.nih.gov/33988758
https://pubmed.ncbi.nlm.nih.gov/33988758
Publikováno v:
Journal of bone and mineral metabolism. 39(3)
There have been no reports of the effects of baseline lumbar spine bone mineral density (LS-BMD) and bone turnover marker levels on the therapeutic effect of a 28.2-μg teriparatide formulation for twice-weekly use (2/W-TPTD). An analysis was perform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5ec1e692abe48ae738f80593bea57d4
https://pubmed.ncbi.nlm.nih.gov/33389132
https://pubmed.ncbi.nlm.nih.gov/33389132